** India's blue-chip indexes Nifty 50 .NSEI and Sensex
.BSESN pare gains after hitting fresh record highs in morning
trade, as a drop in pharma sector weighs
** Dr. Reddy's Laboratories REDY.NS drops 5.5%, leading
losses in Nifty 50 after U.S. drug regulator issues observations
on the drug maker's facility at Hyderabad
** The more domestic-focussed small- .NIFSMCP100 and
mid-caps .NIFMDCP100 up 0.4% and 0.8%, respectively
** Despite the rise, analysts see safety in large-caps due
to return of foreign buying
** "It is safe to stagger investments in small- and mid-caps
in view of the possibility of short-term volatility, says G
Pradeepkumar, chief executive at Union Asset Management Co
** Small- and mid-caps have gained 49% and 42% in 2023 so
far, outperforming the 16% rise in benchmark Nifty 50
** SpiceJet SPJT.BO jumps 15% ahead of results, due later
in the day
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
India's Sensex erases gains after hitting 70,000 mark https://tmsnrt.rs/3t98k8l
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))